Johnston, Donna L <br/><br/>
Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors.  [electronic resource] 

 -  Pediatric blood & cancer  06 2019 
 - e27676 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.27676  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anorexia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Antioxidants--therapeutic use<br/>Child<br/>Child, Preschool<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Melatonin--therapeutic use<br/>Neoplasms--drug therapy<br/>Prognosis<br/>Sleep Wake Disorders--chemically induced<br/>Weight Loss--drug effects